SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : CYPT It's Real -- Ignore unavailable to you. Want to Upgrade?

To: scion who wrote (328)1/11/2004 2:33:44 PM
From: scion  Read Replies (1) | Respond to of 365
 
1. Name and Address of Reporting Person*MARR TECHNOLOGIES BV

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

1. Name and Address of Reporting Person*MARR TECHNOLOGIES BV
-------------------------------------------------------------------------------
(Last) (First) (Middle)
STRAWINSKYLAAN 1431, 1077XX
--------------------------------------------------------------------------------
(Street)AMSTERDAM THE NEDTHERLANDS P7 00000

2. Date of Event Requiring Statement (Month/Day/Year)
09/30/2003
3. Issuer Name and Ticker or Trading Symbol
CALYPTE BIOMEDICAL CORP [CALY]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person
Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)
2. Amount of Securities Owned (Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Common Stock, par value $0.03 per share 38,915,151 D

Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)
2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)
4. Conversion or Excercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
MARR TECHNOLOGIES BV
STRAWINSKYLAAN 1431
1077XX
AMSTERDAM THE NEDTHERLANDS, P7 00000 X
Explanation of Responses:
Christian Strik 10/08/2003
** Signature of Reporting Person Date



To: scion who wrote (328)1/11/2004 2:50:40 PM
From: scion  Read Replies (1) | Respond to of 365
 
Search Results For:    	CALYPTE BIOMEDICAL CORP (899426) 
Modify search 

	Profile,  Financials,  Audit Letter(s),  Annual Reports

Certification Letter(s), Filings w/Exhibits, Insider Summary, Quotes/Charts/News

Total Results:  55
  Search Again | Print View | Add to my Alerts | Add to my Searches | Add to MDL Cart | xlsSnapshot
  Customize Columns | View Transactions 

Company Name 
(Filer Name)	Form
Type	Date 
(Period Ending)	More Info
 	 	 
 
CALYPTE BIOMEDICAL CORP 
(MARR TECHNOLOGIES BV)	SC 13D/A	12/02/2003	FILING
xls

CALYPTE BIOMEDICAL CORP 
(MARR TECHNOLOGIES BV)	3/A	12/02/2003
 (09/30/2003)	FILING
exhibit(s)
xls

CALYPTE BIOMEDICAL CORP 
(MERCATOR ADVISORY GROUP LLC)	SC 13G/A	10/17/2003	FILING 

CALYPTE BIOMEDICAL CORP 
(MERCATOR ADVISORY GROUP LLC)	SC 13G	10/10/2003	FILING 

CALYPTE BIOMEDICAL CORP 
(MARR TECHNOLOGIES BV)	SC 13D/A	10/08/2003	FILING 

CALYPTE BIOMEDICAL CORP 
(MARR TECHNOLOGIES BV)	3	10/08/2003
 (09/30/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(MARR TECHNOLOGIES BV)	SC 13D	10/01/2003	FILING 

CALYPTE BIOMEDICAL CORP 
(MARR TECHNOLOGIES BV)	SC 13D	09/08/2003	FILING 

CALYPTE BIOMEDICAL CORP 
(BRISTOL INVESTMENT FUND LTD)	144	09/04/2003	FILING
xls

CALYPTE BIOMEDICAL CORP 
(HARRISON DIAN J)	5	07/09/2003
 (07/08/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(NOVITCH MARK)	5	07/09/2003
 (07/08/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(KATZ NANCY E)	5	07/01/2003
 (06/30/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(KREVANS JULIUS R)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(HARRISON DIAN J)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(DIPIETRO JOHN J)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(BROUNSTEIN RICHARD D)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(RANDAWA ZAFAR J)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(OYAKAWA JAY)	3	06/04/2003
 (06/03/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(FREIMAN PAUL E)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(NOVITCH MARK)	4/A	06/04/2003
 (06/04/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(CATALDO ANTHONY J)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(KATZ NANCY E)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(NOVITCH MARK)	4	06/04/2003
 (05/29/2003)	FILING 

CALYPTE BIOMEDICAL CORP 
(HARRISON DIAN J)	4	03/11/2003
 (03/10/2003)	FILING
xls

CALYPTE BIOMEDICAL CORP 
(BRISTOL INVESTMENT FUND LTD)	SC 13G/A	03/10/2003	FILING 

CALYPTE BIOMEDICAL CORP 
(HARRISON DIAN J)	3	02/26/2003
 (02/24/2003)	FILING
xls

CALYPTE BIOMEDICAL CORP 
(BRISTOL INVESTMENT FUND LTD)	144	02/12/2003	FILING
xls

CALYPTE BIOMEDICAL CORP 
(ALPHA CAPITAL AKTIENGESELLSCHAFT)	SC 13G/A	02/06/2003	FILING 

CALYPTE BIOMEDICAL CORP 
(KATZ NANCY E)	4	12/19/2002
 (12/17/2002)	FILING
xls

CALYPTE BIOMEDICAL CORP 
(BROUNSTEIN RICHARD D)	4	12/19/2002
 (12/17/2002)	FILING
xls

CALYPTE BIOMEDICAL CORP 
(ALPHA CAPITAL AKTIENGESELLSCHAFT)	SC 13G	11/21/2002	FILING 

CALYPTE BIOMEDICAL CORP 
(LANDAU MARTIN)	5	11/07/2002
 (11/05/2002)	FILING
xls

CALYPTE BIOMEDICAL CORP 
(KATZ NANCY E)	4	11/04/2002
 (10/31/2002)	FILING
xls

CALYPTE BIOMEDICAL CORP 
(DOMINO INTERNATIONAL LTD)	SC 13D	08/29/2002	FILING
xls

CALYPTE BIOMEDICAL CORP 
(CAMDEN INTERNATIONAL LTD)	SC 13D	08/29/2002	FILING
xls

CALYPTE BIOMEDICAL CORP 
(GAVIN DAVID MUN)	SC 13G/A	08/22/2002	FILING 

CALYPTE BIOMEDICAL CORP 
(GAVIN DAVID MUN)	SC 13G	07/23/2002	FILING 

CALYPTE BIOMEDICAL CORP 
(BRISTOL INVESTMENT FUND LTD)	SC 13G	07/01/2002	FILING 

CALYPTE BIOMEDICAL CORP 
(CLANEIL ENTERPRISES INC)	SC 13D/A	03/21/2002	FILING 

CALYPTE BIOMEDICAL CORP 
(H&Q HEALTHCARE INVESTORS)	SC 13G	02/02/2001	FILING 

CALYPTE BIOMEDICAL CORP 
(CLANEIL ENTERPRISES INC)	SC 13D	03/14/2000	FILING
xls

CALYPTE BIOMEDICAL CORP 
(H&Q HEALTHCARE INVESTORS)	SC 13G/A	02/22/2000	FILING 

CALYPTE BIOMEDICAL CORP 
(H&Q HEALTHCARE INVESTORS)	SC 13G/A	02/12/1999	FILING 

CALYPTE BIOMEDICAL CORP 
(SPECIAL SITUATIONS FUND III L P)	SC 13D/A	06/09/1998	FILING 

CALYPTE BIOMEDICAL CORP 
(SUEZ TECHNOLOGY FUND)	SC 13G/A	06/03/1998	FILING 

CALYPTE BIOMEDICAL CORP 
(OTSUKA PHARMACEUTICAL CO LTD)	SC 13G/A	02/17/1998	FILING 

CALYPTE BIOMEDICAL CORP 
(SPECIAL SITUATIONS FUND III L P)	SC 13D	02/10/1998	FILING 

CALYPTE BIOMEDICAL CORP 
(H&Q HEALTHCARE INVESTORS)	SC 13G/A	02/10/1998	FILING 

CALYPTE BIOMEDICAL CORP 
(H&Q HEALTHCARE INVESTORS)	SC 13G	05/15/1997	FILING 

CALYPTE BIOMEDICAL CORP 	SC 13G	03/25/1997	FILING

CALYPTE BIOMEDICAL CORP 
(OTSUKA PHARMACEUTICAL CO LTD)	SC 13G	02/21/1997	FILING
xls

CALYPTE BIOMEDICAL CORP 
(CHIANG KUO-YU)	SC 13G	02/20/1997	FILING
xls

CALYPTE BIOMEDICAL CORP 
(TECHNOLOGY PARTNERS WEST FUND IV L P)	SC 13G	02/14/1997	FILING 

CALYPTE BIOMEDICAL CORP 
(BOEGER WILLIAM A)	SC 13G	02/14/1997	FILING 

CALYPTE BIOMEDICAL CORP 
(SUEZ TECHNOLOGY FUND)	SC 13G	02/14/1997	FILING


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News